UPDATE 1-U.S. court revives Botox-linked shareholder suit against Allergan

Tue Sep 2, 2014 1:33pm EDT

(Adds Allergan comment, background on lawsuit)

By Dan Levine

SAN FRANCISCO, Sept 2 (Reuters) - A U.S. appeals court on Tuesday revived a 2010 shareholder lawsuit against Allergan Inc over allegations the company improperly marketed and labeled the cosmetic drug Botox.

The ruling, from the 9th U.S. Circuit Court of Appeals in San Francisco, said plaintiff shareholders had alleged enough specific facts to proceed.

Allergan, which paid a $375 million criminal fine after being accused of marketing Botox for off-label uses, said the allegations in the shareholder derivative lawsuit have not been proved and the company is confident it will be vindicated.

The lawsuit, filed in 2010, alleged that Allergan's board authorized plans to promote Botox for off-label conditions like headaches and migraines despite knowing the limits of federal drug marketing rules.

A lower court judge in Santa Ana, California dismissed it, saying the shareholders had not followed proper procedure by first requesting that Allergan's board file legal claims in the company's own name.

The 9th Circuit on Tuesday disagreed, saying the shareholders alleged enough specifics to raise doubts as to whether the board faces liability, and as a result do not have to approach the board before heading to court.

The case in the 9th Circuit is Rosenbloom vs. Pyott, 12-55516. (Reporting by Dan Levine; Editing by Chizu Nomiyama and Paul Simao)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

California state worker Albert Jagow (L) goes over his retirement options with Calpers Retirement Program Specialist JeanAnn Kirkpatrick at the Calpers regional office in Sacramento, California October 21, 2009. Calpers, the largest U.S. public pension fund, manages retirement benefits for more than 1.6 million people, with assets comparable in value to the entire GDP of Israel. The Calpers investment portfolio had a historic drop in value, going from a peak of $250 billion in the fall of 2007 to $167 billion in March 2009, a loss of about a third during that period. It is now around $200 billion. REUTERS/Max Whittaker   (UNITED STATES) - RTXPWOZ

How to get out of debt

Financial adviser Eric Brotman offers strategies for cutting debt from student loans and elder care -- and how to avoid money woes in the first place.  Video